Index
1 Prescription Dermatological Drugs Market Overview
1.1 Prescription Dermatological Drugs Product Overview
1.2 Prescription Dermatological Drugs Market Segment by Type
1.2.1 Anti-acne Drugs
1.2.2 Anti-aging Drugs
1.2.3 Dermatitis Drugs
1.2.4 Hair Loss Drugs
1.2.5 Psoriasis Drugs
1.2.6 Skin Cancer Drugs
1.2.7 Melasma Drugs
1.2.8 Seborrhea Drugs
1.3 Global Prescription Dermatological Drugs Market Size by Type
1.3.1 Global Prescription Dermatological Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Prescription Dermatological Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Prescription Dermatological Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prescription Dermatological Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Prescription Dermatological Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Prescription Dermatological Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Prescription Dermatological Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Prescription Dermatological Drugs Sales Breakdown by Type (2018-2023)
2 Global Prescription Dermatological Drugs Market Competition by Company
2.1 Global Top Players by Prescription Dermatological Drugs Sales (2018-2023)
2.2 Global Top Players by Prescription Dermatological Drugs Revenue (2018-2023)
2.3 Global Top Players by Prescription Dermatological Drugs Price (2018-2023)
2.4 Global Top Manufacturers Prescription Dermatological Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prescription Dermatological Drugs Market Competitive Situation and Trends
2.5.1 Prescription Dermatological Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Prescription Dermatological Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prescription Dermatological Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Prescription Dermatological Drugs Market
2.8 Key Manufacturers Prescription Dermatological Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prescription Dermatological Drugs Status and Outlook by Region
3.1 Global Prescription Dermatological Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Prescription Dermatological Drugs Historic Market Size by Region
3.2.1 Global Prescription Dermatological Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Prescription Dermatological Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Prescription Dermatological Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Prescription Dermatological Drugs Forecasted Market Size by Region
3.3.1 Global Prescription Dermatological Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Prescription Dermatological Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Prescription Dermatological Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Prescription Dermatological Drugs by Application
4.1 Prescription Dermatological Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Prescription Dermatological Drugs Market Size by Application
4.2.1 Global Prescription Dermatological Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Prescription Dermatological Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Prescription Dermatological Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prescription Dermatological Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Prescription Dermatological Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Prescription Dermatological Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Prescription Dermatological Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Prescription Dermatological Drugs Sales Breakdown by Application (2018-2023)
5 North America Prescription Dermatological Drugs by Country
5.1 North America Prescription Dermatological Drugs Historic Market Size by Country
5.1.1 North America Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Prescription Dermatological Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Prescription Dermatological Drugs Sales in Value by Country (2018-2023)
5.2 North America Prescription Dermatological Drugs Forecasted Market Size by Country
5.2.1 North America Prescription Dermatological Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Prescription Dermatological Drugs Sales in Value by Country (2024-2029)
6 Europe Prescription Dermatological Drugs by Country
6.1 Europe Prescription Dermatological Drugs Historic Market Size by Country
6.1.1 Europe Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Prescription Dermatological Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Prescription Dermatological Drugs Sales in Value by Country (2018-2023)
6.2 Europe Prescription Dermatological Drugs Forecasted Market Size by Country
6.2.1 Europe Prescription Dermatological Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Prescription Dermatological Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Prescription Dermatological Drugs by Region
7.1 Asia-Pacific Prescription Dermatological Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Prescription Dermatological Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Prescription Dermatological Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Prescription Dermatological Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Prescription Dermatological Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Prescription Dermatological Drugs Sales in Value by Region (2024-2029)
8 Latin America Prescription Dermatological Drugs by Country
8.1 Latin America Prescription Dermatological Drugs Historic Market Size by Country
8.1.1 Latin America Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Prescription Dermatological Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Prescription Dermatological Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Prescription Dermatological Drugs Forecasted Market Size by Country
8.2.1 Latin America Prescription Dermatological Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Prescription Dermatological Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Prescription Dermatological Drugs by Country
9.1 Middle East and Africa Prescription Dermatological Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Prescription Dermatological Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Prescription Dermatological Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Prescription Dermatological Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Prescription Dermatological Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Prescription Dermatological Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Prescription Dermatological Drugs Products Offered
10.2.5 Merck Recent Development
10.3 LEO Pharma
10.3.1 LEO Pharma Company Information
10.3.2 LEO Pharma Introduction and Business Overview
10.3.3 LEO Pharma Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 LEO Pharma Prescription Dermatological Drugs Products Offered
10.3.5 LEO Pharma Recent Development
10.4 Mylan Pharmaceuticals
10.4.1 Mylan Pharmaceuticals Company Information
10.4.2 Mylan Pharmaceuticals Introduction and Business Overview
10.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Products Offered
10.4.5 Mylan Pharmaceuticals Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Prescription Dermatological Drugs Products Offered
10.5.5 Pfizer Recent Development
10.6 Roche
10.6.1 Roche Company Information
10.6.2 Roche Introduction and Business Overview
10.6.3 Roche Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Roche Prescription Dermatological Drugs Products Offered
10.6.5 Roche Recent Development
10.7 Allergan
10.7.1 Allergan Company Information
10.7.2 Allergan Introduction and Business Overview
10.7.3 Allergan Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Allergan Prescription Dermatological Drugs Products Offered
10.7.5 Allergan Recent Development
10.8 Bausch Health
10.8.1 Bausch Health Company Information
10.8.2 Bausch Health Introduction and Business Overview
10.8.3 Bausch Health Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bausch Health Prescription Dermatological Drugs Products Offered
10.8.5 Bausch Health Recent Development
10.9 PharmaDerm Pharmaceuticals
10.9.1 PharmaDerm Pharmaceuticals Company Information
10.9.2 PharmaDerm Pharmaceuticals Introduction and Business Overview
10.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Products Offered
10.9.5 PharmaDerm Pharmaceuticals Recent Development
10.10 Allergan Inamed Corporation
10.10.1 Allergan Inamed Corporation Company Information
10.10.2 Allergan Inamed Corporation Introduction and Business Overview
10.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Products Offered
10.10.5 Allergan Inamed Corporation Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prescription Dermatological Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prescription Dermatological Drugs Industrial Chain Analysis
11.4 Prescription Dermatological Drugs Market Dynamics
11.4.1 Prescription Dermatological Drugs Industry Trends
11.4.2 Prescription Dermatological Drugs Market Drivers
11.4.3 Prescription Dermatological Drugs Market Challenges
11.4.4 Prescription Dermatological Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prescription Dermatological Drugs Distributors
12.3 Prescription Dermatological Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer